Browse

Poster Abstracts

D033

APPLICABILITY OF DYNAMIC RISK STRATIFICATION FOR DIFFERENTIATED THYROID CANCER(DTC) IN A RESOURCE LIMITED SETTING

Endocrine

Karthik Munagala, Shamit Chopra, Anubha Bharthuar

Patel Super Speciality Hospital , Jalandhar , India


D034

PREDICTING MALIGNANCY RATE IN INDETERMINATE THYROID NODULES USING PATIENT DEMOGRAPHICS, NODULE FEATURES AND MOLECULAR TESTING

Endocrine

Guy Talmor, Medical Student, Bhavishya Clark, MD, Sheng Zhou, Medical Student, Tamara N Chambers, MD, Niels C Kokot, MD, Dennis R Maceri, MD

University of Southern California


D035

TRANSORAL ROBOTIC THYROIDECTOMY: THE ERA OF NOTES

Endocrine

1, Zonghui Han1, Michelle Savu, MD1, Bin Zhang, MD2

1Beijing united family Hospital, 2Peking University Cancer Hospital & Institute


D036

TORS VERSUS LATERAL PHARYNGOTOMY FOR MANAGEMENT OF OROPHARYNGEAL CANCER

Mucosal - HPV Negative

Ahmed S Ibrahim, MD, Sydney Coates, BS, Urjeet Patel, MD, Sandeep Samant, MD

Northwestern


D037

HISTOPATHOLOGIC PREDICTORS OF SURVIVAL OUTCOMES IN BUCCAL SQUAMOUS CELL CARCINOMA

Mucosal - HPV Negative

John P Marinelli, BS1, Lisa M Marinelli, BS1, Joaquin J Garcia, MD1, Kyriakos Chatzopoulos, MD1, Tiffany Y Chen, MD2, Eneida F Vencio, DDS, PhD1, Daniel L Price, MD1, Shahm W Raslan, BS3, Christine M Lohse, MS1, Jeffrey R Janus, MD1

1Mayo Clinic, 2Department of Pathology, Brigham and Women's Hospital, Boston MA, 3Herbert Wertheim College of Medicine


D040

ASSESSMENT OF ORAL CANCER INCIDENCE IN AN URBAN POPULATION USING GEOSPATIAL ANALYSIS: A PLATFORM FOR TARGETED SCREENING

Mucosal - HPV Negative

Mihir K Bhayani1, Marynia Kolak, PhD2, Helena Abbey-Peak2, Jayant Pinto, MD2, Cheryl C Nocon, MD1

1NorthShore University HealthSystem, 2University of Chicago


D041

IMPACT OF A TOBACCO TREATMENT PROGRAM ON ABSTINENCE RATES AND SURVIVAL AMONG CURRENT SMOKERS AT THE TIME OF PRIMARY MUCOSAL HEAD AND NECK SQUAMOUS CELL CARCINOMA DIAGNOSIS

Mucosal - HPV Negative

Andrew T Day, MD, MPH1, Kristina R Dahlstrom, PhD2, Rebecca Lee, MS3, Simon C Lee, PhD, MPH1, Maher Karam-Hage, MD2, Paul M Cinciripini2, Erich M Sturgis, MD, MPH2

1UT Southwestern Medical Center, 2UT MD Anderson Cancer Center, 3UT Health Science Center at Houston


D042

AJCC 8TH EDITION ORAL CAVITY PT STAGE: SIGNIFICANT UPSTAGING WITHOUT IMPROVED PROGNOSTICATION FOR PATIENTS WITH EARLY ORAL TONGUE SQUAMOUS CELL CARCINOMA WITH HISTOLOGICALLY NEGATIVE LYMPH NODES

Mucosal - HPV Negative

Shaum Sridharan, MD1, William E Gooding1, Lester D Thompson2, Bibianna Purgina3, Charles D Sturgis4, Akeesha Shah4, Brian Burkey4, Madalina Tuluc5, Manish Bundele Mahadeorao6, Juan Hernandez-Prera7, Dominick Guerrero8, Bin Xu9, Umamaheswar Duvvuri1, Kevin Higgins9, Seungwon Kim1, Robert L Ferris1, Simion I Chiosea1

1University of Pittsburgh Medical Center, 2Southern California Permanente Medical Group, 3The Ottawa Hospital/University of Ottawa, 4Cleveland Clinic, 5Thomas Jefferson University, 6Tan Tock Seng Hospital, 7Moffitt Cancer Center, 8Mount Sinai, 9Sunny Brook Health Sciences Centre


D043

HEAD AND NECK SQUAMOUS CELL CARCINOMA AFTER BONE MARROW TRANSPLANT.

Mucosal - HPV Negative

Catriona M Douglas, MD1, Ashock R Jethwa, MD1, Wael Hasan, MD1, Amy Liu2, J H Lipton3, R Gilbert1, D Goldstein1, J De Almeida*1, J Irish1

1Department of Otolaryngology – Head and Neck Surgical Oncology, University Health Network,, 2Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network and Dalla Lana School of Public Health, University of Toronto, 3Department of Hans Messner Allogeneic Stem Cell Transplant Program, Princess Margaret Cancer Centre, University Health Network, Toronto.


D044

DISTANT METASTASIS IN ORAL SQUAMOUS CELL CARCINOMA

Mucosal - HPV Negative

Daniella Karassawa Zanoni, MD1, Pablo H Montero Miranda, MD2, Jocelyn C Migliacci, MA1, Marlena R McGill, BS1, Jatin P Shah, MD1, Richard J Wong, MD1, Ian Ganly, MD, PhD1, Snehal G Patel, MD1

1Memorial Sloan Kettering Cancer Center, 2Hospital Dr. Sotero del Rio